发明公开
EP1792622A1 Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and EGFR inhibitors or pyrimidine analogues
审中-公开
抗增殖性Kombinationstherapie mit einem Platin enthaltenden chemotherapeuticchen Mittel und EGFR-Inhibitoren oder Pyrimidinanaloga
- 专利标题： Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and EGFR inhibitors or pyrimidine analogues
- 专利标题（中）： 抗增殖性Kombinationstherapie mit einem Platin enthaltenden chemotherapeuticchen Mittel und EGFR-Inhibitoren oder Pyrimidinanaloga
-
申请号： EP05024701.4申请日： 2005-11-11
-
公开(公告)号： EP1792622A1公开(公告)日： 2007-06-06
- 发明人: Wosikowski-Buters, Katja , Schaab, Christoph , Schuhmacher, Marino , Obermayr, Franz , Ivanov, Igor
- 申请人： GPC Biotech AG
- 申请人地址： Fraunhoferstrasse 20 82152 Martinsried DE
- 专利权人： GPC Biotech AG
- 当前专利权人： GPC Biotech AG
- 当前专利权人地址： Fraunhoferstrasse 20 82152 Martinsried DE
- 代理机构： Dörries, Hans Ulrich
- 主分类号： A61K33/24
- IPC分类号： A61K33/24 ; A61K31/505 ; A61P35/00
摘要：
This invention relates to a method or uses of prevention and/or treatment of a cancer or a tumor, and in particular to a combination therapy, methods, compositions and pharmaceutical packages comprising an inhibitor or receptors of the EGFR family or a chemotherapeutically active pyrimidine analogue and certain platinum-based chemotherapeutic agents.
信息查询
